伤寒与副伤寒沙门菌耐药表型与全基因组测序预测谱比较
该研究对603株伤寒与副伤寒沙门菌(伤寒332株、副伤寒271株)用WGS预测耐药并与EUCAT折点的表型药敏比较,仅2/6030组合不一致。伤寒多药耐药占25.0%,伤寒对环丙沙星耐药10.8%,副伤寒甲对环丙沙星耐药高达92.1%,未检出阿奇霉素或三代头孢耐药。
要点
- WGS预测与表型药敏高度一致,可用于耐药监测与经验治疗参考。
- 伤寒沙门菌多药耐药占25.0%,副伤寒未检出多药耐药。
- 副伤寒甲对环丙沙星耐药达92.1%,高于伤寒沙门菌的10.8%。
核心结论
- WGS数据为监测伤寒与副伤寒沙门菌多药耐药及环丙沙星耐药提供了可靠且信息丰富的方法。
- 表型药敏仍用于指导个体化治疗,而WGS推断的耐药谱可用于监测和经验治疗。
研究设计与样本
- 对603株沙门菌分离株(伤寒沙门菌332株、副伤寒沙门菌271株)进行WGS分析,映射至已知耐药基因或染色体突变。
- 将WGS预测的耐药与按EUCAT推荐折点解读的表型药敏数据进行比较。
主要发现
- 6030个分离株/抗菌药物类别组合中仅2个(0.03%)判读不一致。
- 伤寒沙门菌中检出多药耐药(对三类或以上抗菌药物耐药)83/332(25.0%),副伤寒沙门菌未检出。
- 副伤寒甲沙门菌对环丙沙星耐药(MIC >0.5 mg/L)209/227(92.1%)。
- 未检出对阿奇霉素或三代头孢菌素的耐药。
关键数值与推荐
- 表型药敏判读采用EUCAT推荐的折点。
- 多药耐药定义为对三类或以上抗菌药物类别耐药。
- 环丙沙星耐药定义为MIC >0.5 mg/L;敏感性降低定义为MIC 0.06-0.25 mg/L。
临床怎么用
- 临床个体化治疗仍应以表型药敏结果为指导。
- WGS推断的耐药谱可用于耐药监测和辅助经验性治疗方案制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Surveillance of antimicrobial resistance (AMR) in Salmonella enterica serovars Typhi and Paratyphi is essential to provide an evidence base for empirical treatment protocols and to monitor emerging AMR. We sought to compare phenotypic and WGS-based genotypic methods for the detection of AMR in Salmonella Typhi and Salmonella Paratyphi. METHODS: WGS data from 603 isolates of Salmonella Typhi (n = 332) and Salmonella Paratyphi (n = 271) were mapped to genes or chromosomal mutations known to be associated with phenotypic AMR and compared with phenotypic susceptibility data interpreted using breakpoints recommended by EUCAST. RESULTS: There were two (0.03%) discordant interpretations out of a possible 6030 isolate/antimicrobial class combinations. MDR (resistant to three or more classes of antimicrobial) was detected in 83/332 (25.0%) Salmonella Typhi isolates, but was not detected in Salmonella Paratyphi. Thirty-six (10.8%) isolates of Salmonella Typhi were resistant to ciprofloxacin (MIC >0.5 mg/L), with 33 (9.9%) of 332 exhibiting mutations in gyrA and parC, and 244 (73.5%) isolates had reduced susceptibility to ciprofloxacin (MIC 0.06-0.25 mg/L). In comparison, 209/227 (92.1%) isolates of Salmonella Paratyphi A exhibited resistance to ciprofloxacin (MIC >0.5 mg/L). No resistance to azithromycin or the third-generation cephalosporins was detected. CONCLUSIONS: WGS data provided a robust and informative approach for monitoring MDR and emerging resistance to ciprofloxacin in Salmonella Typhi and Salmonella Paratyphi. Phenotypic antimicrobial susceptibility testing continues to be performed to guide targeted individual patient treatment, but inferred AMR profiles from WGS data may be used for surveillance and to guide empirical therapy.
引用
- Day MR, Doumith M, Do Nascimento V, et al. Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi. J Antimicrob Chemother. 2018. PMID: 29216342. doi:10.1093/jac/dkx379
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。